Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
9.210
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
9.210
Bid (Size)
9.270 (100)
Ask (Size)
9.300 (500)
Prev. Close
9.210
Today's Range
9.210 - 9.210
52wk Range
5.690 - 13.24
Shares Outstanding
259,965,579
Dividend Yield
0.87%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis
April 15, 2026
From
Organon & Co.
Via
Business Wire
3 Reasons to Avoid OGN and 1 Stock to Buy Instead
April 13, 2026
Over the last six months, Organon’s shares have sunk to $9.03, producing a disappointing 5.9% loss - a stark contrast to the S&P 500’s 2.5% gain. This may ha...
Via
StockStory
Topics
Stocks
Performance
YTD
+27.2%
+27.2%
1 Month
+45.3%
+45.3%
3 Month
+7.0%
+7.0%
6 Month
-3.6%
-3.6%
1 Year
-16.7%
-16.7%
More News
Read More
Traders are paying attention to the gapping stocks in Friday's session.
↗
April 10, 2026
Via
Chartmill
Topics
Artificial Intelligence
Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook
↗
February 12, 2026
Via
Chartmill
Topics
Earnings
Discover the top movers in Friday's pre-market session.
↗
April 10, 2026
Via
Chartmill
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
April 06, 2026
Via
StockStory
Topics
Government
Stocks
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age
March 27, 2026
From
Organon & Co.
Via
Business Wire
3 Cash-Producing Stocks We’re Skeptical Of
March 23, 2026
Via
StockStory
Topics
Fraud
Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?
↗
March 20, 2026
Via
The Motley Fool
3 Value Stocks We Approach with Caution
March 20, 2026
Via
StockStory
1 Stock Under $10 to Own for Decades and 2 That Underwhelm
March 19, 2026
Via
StockStory
3 of Wall Street’s Favorite Stocks We Approach with Caution
March 13, 2026
Via
StockStory
3 Small-Cap Stocks We Approach with Caution
March 04, 2026
Via
StockStory
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis
February 27, 2026
From
Organon & Co.
Via
Business Wire
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
February 26, 2026
Via
Finterra
Topics
Economy
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
February 23, 2026
From
Organon & Co.
Via
Business Wire
5 Revealing Analyst Questions From Organon’s Q4 Earnings Call
February 19, 2026
Via
StockStory
Topics
Earnings
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know
February 13, 2026
Via
StockStory
Topics
Economy
OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook
February 13, 2026
Via
StockStory
Organon (OGN) Q4 2025 Earnings Call Transcript
↗
February 12, 2026
Via
The Motley Fool
Topics
Earnings
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations
February 12, 2026
Via
StockStory
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
February 12, 2026
From
Organon & Co.
Via
Business Wire
Organon Earnings: What To Look For From OGN
February 10, 2026
Via
StockStory
Topics
Artificial Intelligence
World Trade
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off
February 04, 2026
Via
StockStory
Topics
Stocks
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
January 29, 2026
From
Organon & Co.
Via
Business Wire
Frequently Asked Questions
Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 9.210
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 04/15/26 07:00 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 2.39B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.